National Cancer Center Korea: leading the way in proton therapy for South Korea

Описание: The National Cancer Center Korea (NCCK) in Goyang-si, Seoul, South Korea, is the first government-established cancer-specialized center in South Korea. NCCK is at the forefront of providing advanced cancer treatments, including proton therapy. The video provides an inside look into the center's state-of-the-art facilities and highlights how proton therapy is transforming the treatment of various cancers.

Dr. Hong Gwan Seo, MD, PhD, President of NCCK, discusses the center’s evolution since its founding in 2000. The center’s pioneering proton therapy program, launched in 2007, has already treated over 70,000 patients, making it a leader in the field. Through its partnership with IBA ProteusONE, NCCK continues to enhance proton therapy’s accessibility and quality.

Dr. Tae Hyun Kim, MD, PhD, director of the Proton Therapy Center at NCCK, highlights how NCCK has treated various cancers, including liver, esophageal, and pediatric cancers, using proton therapy. The center also leads in clinical research and technology development in collaboration with global partners like IBA.


13:37

Dr. Dongho Shin, PhD, NCCK's Chief Medical Physicist, shares the advancements that make proton therapy possible, such as the world’s first eye-tracking system for eye tumors. The team continues to innovate with technologies like FLASH and Arc Therapy, expanding proton therapy’s capabilities.

Dr. Joo-Young Kim, MD, PhD a pediatric radiation oncologist at NKKC, discusses how proton therapy reduces long-term side effects for children and adolescents. Proton therapy offers significant benefits for young patients by minimizing the long-term side effects often caused by traditional radiation therapies.

Dr. Sung Hoo Moon, MD, PhD, a radiation oncologist at NCCK, explains how proton therapy is revolutionizing the treatment of esophageal and ocular cancers. Proton therapy's precision reduces radiation damage to surrounding organs, improving patient outcomes and reducing complications.


Key Highlights:

(00:00) Introduction to NKKC: the first cancer center in South Korea

(01:39) NKKC’s journey in cancer care and proton therapy

(03:01) Virtual tour of the NCCK proton therapy unit

(09:18) Core principles and benefits of proton therapy.

(11:53) Advancements in cancer treatment using proton therapy

(13:04) Virtual tour of the proton therapy machine

(19:10) Proton therapy treatment procedures

(21:15) Pediatric patient proton therapy treatment

(24:00) Proton ocular treatment


NKKC: National Cancer Center Korea


📚 Curious about proton therapy? Take a closer look here: https://www.iba-protontherapy.com/wha...


#ProtonTherapy #MedicalPhysics #RadiationOncology #PrecisionRadiotherapy #MedicalDevice #HealthcareTechnology #MedicalTechnology #ProtonTherapyCenter #IBAPartnership #MedicalPartnership #MedicalCollaboration #CancerCenter #PediatricCancer #EsophagealCancer #OcularCancer #EyeTumor #ProteusONE #FLASHTherapy #ArcTherapy #PatientSafety #PatientCare #PatientCenteredCare #ComprehensiveCare #NKKC

Disclaimer:

The statements of the healthcare professional included in this testimonial reflect only his opinion and personal experience. They do not necessarily reflect the opinion of any institution with whom he is affiliated or IBA.


▬ Learn more ▬▬▬▬▬▬▬▬▬▬▬

Radiation Oncology with ProteusONE | IBA Proton Therapy    • Radiation Oncology with ProteusONE | IBA P...  


360° tour of a proton therapy center with ProteusONE    • 360° tour of a proton therapy center with ...  


Proton therapy workflow with ProteusONE    • Proton therapy workflow with ProteusONE  


▬ Follow us ▬▬▬▬▬▬▬▬▬▬▬▬

Discover us on LinkedIn:   / iba-proton-therapy  


Find us on Facebook:   / ibatoday  


Subscribe to this YouTube channel:    / @ibaprotontherapy  


▬ About IBA ▬▬▬▬▬▬▬▬▬▬▬▬

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance."